Completing all 12 cycles of Neratinib is essential for maximizing overall survival outcomes. Dr. Kang explains the dramatic difference in patient outcomes associated with treatment completion versus early discontinuation, and shares proactive management strategies to ensure patients receive the full benefit of therapy.
